Celltrion applied for European approval of biosimilar antibody for the second time

On the 11^th, Celltion announced the European Medicines Agency(EMA) received the document for the approval application of CT-P10 on the 10^th of November(local time).

Since the company has followed the same approval process, the EMA Centralized procedure, as the first products entered to the European market, Remsima, it expressed the approval is just like getting approvals from the 31 European c...